• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威布尔函数对利巴韦林在人体中的药代动力学数据进行拟合。

Weibull function fits to pharmacokinetic data of ribavirin in man.

作者信息

Liu X D, Xie L, Han K Q, Liu G Q

机构信息

Department of Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, Jiangsu Province, People's Republic of China.

出版信息

Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):227-31. doi: 10.1007/BF03189718.

DOI:10.1007/BF03189718
PMID:8980920
Abstract

Weibull function C = Bts-1exp(-lambda ts) was used to describe plasma concentration-time data of ribavirin in 6 healthy subjects following an i.v. dose of 600 mg. A good fit was found in each of the subjects, where the coefficients of determination r2 were > 0.99. The parameters estimated were as follows: B, 5.90 +/- 1.86 micrograms.h1-s; lambda, 0.607 +/- 0.156 h-s; and s, 0.339 +/- 0.085, respectively. The results were compared with those by triexponential function. By providing lower values of AIC and SD, as well as higher values of r2, the Weibull function proved to be superior to triexponential function for data of 3 subjects. These results indicated that both Weibull function and triexponential function provided a good fit of plasma concentration-time data of ribavirin in man following an i.v. dose.

摘要

威布尔函数(C = Bt^{s - 1}\exp(-\lambda t^{s}))用于描述6名健康受试者静脉注射600mg利巴韦林后的血浆浓度-时间数据。在每个受试者中均发现拟合良好,其中决定系数(r^{2}\gt0.99)。估计的参数如下:(B)为(5.90\pm1.86)微克·(h^{1 - s});(\lambda)为(0.607\pm0.156) (h^{- s});(s)为(0.339\pm0.085)。将结果与用三指数函数得到的结果进行比较。通过提供更低的AIC和SD值以及更高的(r^{2})值,对于3名受试者的数据,威布尔函数被证明优于三指数函数。这些结果表明,威布尔函数和三指数函数均能很好地拟合人静脉注射利巴韦林后的血浆浓度-时间数据。

相似文献

1
Weibull function fits to pharmacokinetic data of ribavirin in man.威布尔函数对利巴韦林在人体中的药代动力学数据进行拟合。
Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):227-31. doi: 10.1007/BF03189718.
2
Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.在健康受试者中,利巴韦林与替诺福韦之间不存在具有临床相关性的药代动力学相互作用。
J Clin Pharmacol. 2006 May;46(5):559-66. doi: 10.1177/0091270006287704.
3
Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment.单剂量利巴韦林在慢性肾功能损害患者中的药代动力学和安全性
Drug Discov Ther. 2013 Aug;7(4):158-63.
4
Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection.利巴韦林前体药物维拉美啶在代偿性丙型肝炎感染成年受试者中的多次递增剂量药代动力学。
J Clin Pharmacol. 2005 Mar;45(3):275-85. doi: 10.1177/0091270004270152.
5
Comparative pharmacokinetic analysis by standard two-stage method versus nonparametric population modeling.采用标准两阶段法与非参数群体建模的比较药代动力学分析。
Pharmacotherapy. 2003 Dec;23(12):1545-9. doi: 10.1592/phco.23.15.1545.31969.
6
Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者血浆和细胞内利巴韦林浓度的群体药代动力学建模
Antimicrob Agents Chemother. 2015 Apr;59(4):2179-88. doi: 10.1128/AAC.04618-14. Epub 2015 Feb 2.
7
Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology.用稳定同位素法测定健康志愿者中利巴韦林的药代动力学和绝对生物利用度。
Antimicrob Agents Chemother. 1999 Oct;43(10):2451-6. doi: 10.1128/AAC.43.10.2451.
8
Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.利巴韦林前体药物维拉美啶在健康志愿者体内的药代动力学及安全性
J Clin Pharmacol. 2004 Mar;44(3):265-75. doi: 10.1177/0091270004262974.
9
Ribavirin plasma concentration measurements in patients with hepatitis C: early ribavirin concentrations predict steady-state concentrations.丙型肝炎患者的利巴韦林血浆浓度测量:早期利巴韦林浓度可预测稳态浓度。
Ther Drug Monit. 2011 Feb;33(1):40-4. doi: 10.1097/FTD.0b013e318205f892.
10
Sensitive and specific LC-MS/MS method for the simultaneous measurements of viramidine and ribavirin in human plasma.用于同时测定人血浆中维拉美定和利巴韦林的灵敏且特异的液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 17;832(1):17-23. doi: 10.1016/j.jchromb.2005.12.034.

引用本文的文献

1
Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha.纳米药物在治疗合并感染HIV的丙型肝炎患者中的应用——聚焦于聚乙二醇化干扰素-α
Int J Nanomedicine. 2006;1(4):399-409. doi: 10.2147/nano.2006.1.4.399.

本文引用的文献

1
[Two aspects about curve fitting in pharmacokinetics; weighting of experimental data and discrimination between linear compartmental models (author's transl)].
Yao Xue Xue Bao. 1980 Sep;15(9):571-6.
2
[A non-linear method and its program for calculating pharmacokinetic parameters].
Zhongguo Yao Li Xue Bao. 1983 Dec;4(4):217-20.
3
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.病毒唑的广谱抗病毒活性:1-β-D-呋喃核糖基-1,2,4-三唑-3-甲酰胺。
Science. 1972 Aug 25;177(4050):705-6. doi: 10.1126/science.177.4050.705.
4
In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.1-β-D-呋喃核糖基-1,2,4-三唑-3-甲酰胺(病毒唑,ICN 1229)对脱氧核糖核酸病毒和核糖核酸病毒的体外作用
Antimicrob Agents Chemother. 1973 Feb;3(2):235-41. doi: 10.1128/AAC.3.2.235.
5
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.利巴韦林在获得性免疫缺陷综合征高危患者中的处置情况。
Clin Pharmacol Ther. 1987 May;41(5):546-55. doi: 10.1038/clpt.1987.70.
6
High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassay.利巴韦林的高效液相色谱(HPLC)测定法及HPLC测定法与放射免疫测定法的比较。
Antimicrob Agents Chemother. 1989 Mar;33(3):311-5. doi: 10.1128/AAC.33.3.311.
7
Pharmacokinetic stochastic model with Weibull-distributed residence times of drug molecules in the body.
Eur J Clin Pharmacol. 1987;32(5):515-23. doi: 10.1007/BF00637680.
8
Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.赤池信息准则(AIC)在线性药代动力学方程评估中的应用。
J Pharmacokinet Biopharm. 1978 Apr;6(2):165-75. doi: 10.1007/BF01117450.